Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Comparing the Cardiovascular Risk-Reducing Effects of Polyunsaturated Fatty Acids in Fish Oil and Krill Oil: A Network Meta-Analysis

Version 1 : Received: 1 May 2024 / Approved: 2 May 2024 / Online: 2 May 2024 (10:03:55 CEST)

A peer-reviewed article of this Preprint also exists.

Pham, T.-P.-T.; Hoang, T.-V.; Le, T.-T.-D.; Cao, P.-T.-N.; Ho, V.-T.-N.; Vu, T.-M.-H.; Le, T.-H.-T.; Pham, H.-T.-X.; Ratna Mafruhah, O.; Pham, T.-T.-L.; et al. Comparing the Cardiovascular Risk-Reducing Effects of Polyunsaturated Fatty Acids in Fish Oil and Krill Oil: A Network Meta-Analysis. Journal of Functional Foods 2024, 120, 106379, doi:10.1016/j.jff.2024.106379. Pham, T.-P.-T.; Hoang, T.-V.; Le, T.-T.-D.; Cao, P.-T.-N.; Ho, V.-T.-N.; Vu, T.-M.-H.; Le, T.-H.-T.; Pham, H.-T.-X.; Ratna Mafruhah, O.; Pham, T.-T.-L.; et al. Comparing the Cardiovascular Risk-Reducing Effects of Polyunsaturated Fatty Acids in Fish Oil and Krill Oil: A Network Meta-Analysis. Journal of Functional Foods 2024, 120, 106379, doi:10.1016/j.jff.2024.106379.

Abstract

The study aimed to compare the cardiovascular benefits of Omega-3 Polyunsaturated Fatty Acids from fish oil versus krill oil in different forms and dosages. Following PRISMA 2015, data analysis with R software, and databases were searched from 1993 to 2023, (ID PROSPERO: CRD42024502338). Sixty high-quality studies were analyzed, covering various forms of fish oil and krill oil at different dosages (fish oil (ethyl ester-EE, triglyceride-TG, re-esterified triglycerides-rTG, capsules, emulsion-EM); krill oil (phospholipid/free fatty acid-PL/FFA, high concentration phospholipid-HPL, low concentration phospholipid-LPL)). Meta-analysis revealed that krill oil with phospholipid/free fatty acid at doses 2000-2900 mg effectively lowered triglycerides, while fish oil in ethyl ester form at doses above 3000 mg significantly reduced total cholesterol. Fish oil in triglyceride form at doses 2000-2900 mg and other variations positively impacted HDL-C levels. Fish oil in EE form above 3000 mg and triglyceride form below 2000 mg notably reduced LDL-C. However, there was limited effectiveness observed for other interventions. Analysis for LDL-C exhibited publication bias, while other parameters demonstrated reliability (Egger's test). In conclusion, krill oil - PL/FFA, Fish oil - EE above 3000 mg, Fish oil - TG 2000-3000 mg, and fish oil - rTAG 300-1900 mg effectively in reducing heart risk patients.

Keywords

Cardiovascular Disease; Omega-3 Polyunsaturated Fatty Acids; Fish Oil; Krill Oil; Triglycerides; Cholesterols.

Subject

Medicine and Pharmacology, Dietetics and Nutrition

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.